hotspot -WSS

hotspot

author：entertainment 2025-09-30 00:47:53 - browse：271

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Hilary expected to bring catastrophic, life

WSS

CDC concerned about possible undetected monkeypox spread in U.K.

Gene therapy has helped boys walk. Can scientists keep it that way?

An interview with Robert F. Kennedy Jr. on vaccines

ProMED sees offers of support, but its future remains unclear

An interview with Robert F. Kennedy Jr. on vaccines

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

entertainment

hotspot

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Death of patient in Alzheimer’s trial raises question of possible risks

Hepatitis C has a cure — but many Americans still lack access to it

Hilary expected to bring catastrophic, life

Apple is now the first public company to be valued at $3 trillion

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The boys, now 6, who are gene therapy’s ‘edge case’ problem

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cloning humans is technically possible. It's curious no one has tried

leisure time

Why are elite athletes different? Take a look at their microbes

Paxlovid study fails to answer questions over benefit for broader groups

Death of patient in Alzheimer’s trial raises question of possible risks

Paxlovid study fails to answer questions over benefit for broader groups

New definition of a human embryo proposed amid rapid advances

The pain doctors face in trying to build their families

leisure time

hotspot

hotspot

knowledge